{"title":"一名中国复发性子宫肌瘤患者富马酸氢化酶基因中的新型无义突变","authors":"Yiyin Ruan B.Sc., Weiwei Feng M.D., Ph.D., Chenmin Yang M.D., Ph.D.","doi":"10.1016/j.xfre.2023.08.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To describe a novel nonsense mutation in the fumarate hydratase (FH) gene in a Chinese patient with recurrent multiple leiomyomas.</p></div><div><h3>Design</h3><p>Case report.</p></div><div><h3>Setting</h3><p>Medical school-affiliated tertiary hospital.</p></div><div><h3>Patient(s)</h3><p>A nulligravida patient aged 30 years with large uterine leiomyomas (ULMs) and severe anemia.</p></div><div><h3>Intervention(s)</h3><p>Clinical evaluation, abdominal myomectomy, targeted next-generation sequencing.</p></div><div><h3>Main outcome measure(s)</h3><p>Fumarate hydratase gene mutation in ULMs.</p></div><div><h3>Result(s)</h3><p>A novel nonsense mutation (c.771T>G) in the <em>FH</em> gene was identified in this patient. This mutation is located in exon 6, which encodes the N-terminal fumarate lyase domain. It leads to a predicted truncated protein with loss of the majority of the lyase domain, resulting in FH deficiency.</p></div><div><h3>Conclusion(s)</h3><p>Because of the recurrent multiple leiomyomas, this patient received 2 myomectomies within 5 years. On immunostaining the leiomyoma, FH deficiency was detected, and targeted next-generation sequencing revealed a novel mutation of the <em>FH</em> gene. This patient was at risk for early disease relapse and developing renal cancer, and close disease monitoring is recommended. Meanwhile, the expanded mutation database should benefit patients in diagnosing <em>FH</em> gene-associated ULMs.</p></div>","PeriodicalId":34409,"journal":{"name":"FS Reports","volume":"4 4","pages":"Pages 410-415"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666334123000867/pdfft?md5=d6cbee60c36c09ad7b1559ea0f65677b&pid=1-s2.0-S2666334123000867-main.pdf","citationCount":"0","resultStr":"{\"title\":\"A novel nonsense mutation in the fumarate hydratase gene in a Chinese patient with recurrent leiomyomas\",\"authors\":\"Yiyin Ruan B.Sc., Weiwei Feng M.D., Ph.D., Chenmin Yang M.D., Ph.D.\",\"doi\":\"10.1016/j.xfre.2023.08.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>To describe a novel nonsense mutation in the fumarate hydratase (FH) gene in a Chinese patient with recurrent multiple leiomyomas.</p></div><div><h3>Design</h3><p>Case report.</p></div><div><h3>Setting</h3><p>Medical school-affiliated tertiary hospital.</p></div><div><h3>Patient(s)</h3><p>A nulligravida patient aged 30 years with large uterine leiomyomas (ULMs) and severe anemia.</p></div><div><h3>Intervention(s)</h3><p>Clinical evaluation, abdominal myomectomy, targeted next-generation sequencing.</p></div><div><h3>Main outcome measure(s)</h3><p>Fumarate hydratase gene mutation in ULMs.</p></div><div><h3>Result(s)</h3><p>A novel nonsense mutation (c.771T>G) in the <em>FH</em> gene was identified in this patient. This mutation is located in exon 6, which encodes the N-terminal fumarate lyase domain. It leads to a predicted truncated protein with loss of the majority of the lyase domain, resulting in FH deficiency.</p></div><div><h3>Conclusion(s)</h3><p>Because of the recurrent multiple leiomyomas, this patient received 2 myomectomies within 5 years. On immunostaining the leiomyoma, FH deficiency was detected, and targeted next-generation sequencing revealed a novel mutation of the <em>FH</em> gene. This patient was at risk for early disease relapse and developing renal cancer, and close disease monitoring is recommended. Meanwhile, the expanded mutation database should benefit patients in diagnosing <em>FH</em> gene-associated ULMs.</p></div>\",\"PeriodicalId\":34409,\"journal\":{\"name\":\"FS Reports\",\"volume\":\"4 4\",\"pages\":\"Pages 410-415\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2666334123000867/pdfft?md5=d6cbee60c36c09ad7b1559ea0f65677b&pid=1-s2.0-S2666334123000867-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"FS Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666334123000867\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"FS Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666334123000867","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的描述一名复发性多发性子宫肌瘤中国患者的富马酸氢化酶(FH)基因中的新型无义突变。干预措施临床评估、腹腔子宫肌瘤剔除术、靶向新一代测序。主要结局指标富马酸氢化酶基因在多发性子宫肌瘤中的突变。T>G)。该突变位于编码 N 端富马酸裂解酶结构域的第 6 号外显子。结论:由于复发性多发性子宫肌瘤,该患者在 5 年内接受了 2 次子宫肌瘤切除术。免疫染色法检测出该子宫肌瘤存在FH缺乏症,靶向新一代测序发现了FH基因的新型突变。该患者有早期疾病复发和发展为肾癌的风险,建议密切监测病情。同时,扩大的基因突变数据库将有助于患者诊断与FH基因相关的超低密度肌瘤。
A novel nonsense mutation (c.771T>G) in the FH gene was identified in this patient. This mutation is located in exon 6, which encodes the N-terminal fumarate lyase domain. It leads to a predicted truncated protein with loss of the majority of the lyase domain, resulting in FH deficiency.
Conclusion(s)
Because of the recurrent multiple leiomyomas, this patient received 2 myomectomies within 5 years. On immunostaining the leiomyoma, FH deficiency was detected, and targeted next-generation sequencing revealed a novel mutation of the FH gene. This patient was at risk for early disease relapse and developing renal cancer, and close disease monitoring is recommended. Meanwhile, the expanded mutation database should benefit patients in diagnosing FH gene-associated ULMs.